Literature DB >> 21555530

Nitric oxide modulates TGF-beta-directive signals to suppress Foxp3+ regulatory T cell differentiation and potentiate Th1 development.

Seung-Woo Lee1, Heonsik Choi, So-Young Eun, Satoshi Fukuyama, Michael Croft.   

Abstract

TGF-β can induce Foxp3(+) inducible regulatory T cells (Treg) and also synergize with IL-6 and IL-4 to induce Th17 and Th9 cells. We now report that NO modulates TGF-β activity away from Treg but toward the Th1 lineage. NO potentiated Th1 differentiation in the presence of TGF-β in both IL-12-independent and -dependent fashions by augmenting IFN-γ-activated STAT-1 and T-bet. Differentiation into Treg, Th1, and Th17 lineages could be modulated by NO competing with other cofactors, such as IL-6 and retinoic acid. NO antagonized IL-6 to block TGF-β-directed Th17 differentiation, and together with IL-6, NO suppressed Treg development induced by TGF-β and retinoic acid. Furthermore, we show that physiologically produced NO from TNF and inducible NO synthase-producing dendritic cells can contribute to Th1 development predominating over Treg development through a synergistic activity induced when these cells cocluster with conventional dendritic cells presenting Ag to naive Th cells. This illustrates that NO is another cofactor allowing TGF-β to participate in development of multiple Th lineages and suggests a new mechanism by which NO, which is associated with protection against intracellular pathogens, might maintain effective Th1 immunity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21555530      PMCID: PMC3113707          DOI: 10.4049/jimmunol.1100485

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

Review 1.  Nitrosylation. the prototypic redox-based signaling mechanism.

Authors:  J S Stamler; S Lamas; F C Fang
Journal:  Cell       Date:  2001-09-21       Impact factor: 41.582

2.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

3.  Activation of cGMP-dependent protein kinase Ibeta inhibits interleukin 2 release and proliferation of T cell receptor-stimulated human peripheral T cells.

Authors:  T A Fischer; A Palmetshofer; S Gambaryan; E Butt; C Jassoy; U Walter; S Sopper; S M Lohmann
Journal:  J Biol Chem       Date:  2000-11-09       Impact factor: 5.157

4.  TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection.

Authors:  Jerry R Aldridge; Carson E Moseley; David A Boltz; Nicholas J Negovetich; Cory Reynolds; John Franks; Scott A Brown; Peter C Doherty; Robert G Webster; Paul G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-11       Impact factor: 11.205

5.  Inhibition of nitric oxide production by the carbazole compound LCY-2-CHO via blockade of activator protein-1 and CCAAT/enhancer-binding protein activation in microglia.

Authors:  Ling-Chu Chang; Lo-Ti Tsao; Chi-Sen Chang; Chun-Jung Chen; Li-Jiau Huang; Sheng-Chu Kuo; Ruey-Hseng Lin; Jih-Pyang Wang
Journal:  Biochem Pharmacol       Date:  2008-06-10       Impact factor: 5.858

6.  S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis.

Authors:  Narender Nath; Osamu Morinaga; Inderjit Singh
Journal:  J Neuroimmune Pharmacol       Date:  2010-01-21       Impact factor: 4.147

7.  Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.

Authors:  Marc Veldhoen; Catherine Uyttenhove; Jacques van Snick; Helena Helmby; Astrid Westendorf; Jan Buer; Bruno Martin; Christoph Wilhelm; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2008-10-19       Impact factor: 25.606

8.  Regulation of hierarchical clustering and activation of innate immune cells by dendritic cells.

Authors:  Suk-Jo Kang; Hong-Erh Liang; Boris Reizis; Richard M Locksley
Journal:  Immunity       Date:  2008-11-14       Impact factor: 31.745

9.  IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.

Authors:  Valérie Dardalhon; Amit Awasthi; Hyoung Kwon; George Galileos; Wenda Gao; Raymond A Sobel; Meike Mitsdoerffer; Terry B Strom; Wassim Elyaman; I-Cheng Ho; Samia Khoury; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

10.  iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice.

Authors:  Carl De Trez; Stefan Magez; Shizuo Akira; Bernhard Ryffel; Yves Carlier; Eric Muraille
Journal:  PLoS Pathog       Date:  2009-06-26       Impact factor: 6.823

View more
  21 in total

1.  Hypertensive female Sprague-Dawley rats require an intact nitric oxide synthase system for compensatory increases in renal regulatory T cells.

Authors:  Lindsey A Ramirez; Ellen E Gillis; Jacqueline B Musall; Riyaz Mohamed; Elizabeth Snyder; Ahmed El-Marakby; Jennifer C Sullivan
Journal:  Am J Physiol Renal Physiol       Date:  2020-06-29

2.  Effects of ginsenosides on regulatory T cell differentiation.

Authors:  Jisu Kim; Hyeyoung Byeon; Kyungtaek Im; Hyeyoung Min
Journal:  Food Sci Biotechnol       Date:  2017-11-23       Impact factor: 2.391

3.  Poly(cyclodextrin)-Polydrug Nanocomplexes as Synthetic Oncolytic Virus for Locoregional Melanoma Chemoimmunotherapy.

Authors:  Jihoon Kim; Lauren F Sestito; Sooseok Im; Won Jong Kim; Susan N Thomas
Journal:  Adv Funct Mater       Date:  2020-02-24       Impact factor: 18.808

4.  CTLA4Ig inhibits effector T cells through regulatory T cells and TGF-β.

Authors:  Christine M Deppong; Traci L Bricker; Brandy D Rannals; Nico Van Rooijen; Chyi-Song Hsieh; Jonathan M Green
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

5.  Nitric oxide inhibits the accumulation of CD4+CD44hiTbet+CD69lo T cells in mycobacterial infection.

Authors:  John E Pearl; Egidio Torrado; Michael Tighe; Jeffrey J Fountain; Alejandra Solache; Tara Strutt; Susan Swain; Rui Appelberg; Andrea M Cooper
Journal:  Eur J Immunol       Date:  2012-09-26       Impact factor: 5.532

6.  CD28 ligation increases macrophage suppression of T-cell proliferation.

Authors:  Daniel Silberman; Amanda Bucknum; Thomas Bartlett; Gabriella Composto; Megan Kozlowski; Amanda Walker; Amy Werda; Jackelyn Cua; Arlene H Sharpe; John E Somerville; James E Riggs
Journal:  Cell Mol Immunol       Date:  2012-04-23       Impact factor: 11.530

Review 7.  Dual targeting of the thioredoxin and glutathione systems in cancer and HIV.

Authors:  Moran Benhar; Iart Luca Shytaj; Jonathan S Stamler; Andrea Savarino
Journal:  J Clin Invest       Date:  2016-05-02       Impact factor: 14.808

Review 8.  Nitrosothiols in the immune system: signaling and protection.

Authors:  Pablo Hernansanz-Agustín; Alicia Izquierdo-Álvarez; Almudena García-Ortiz; Sales Ibiza; Juan M Serrador; Antonio Martínez-Ruiz
Journal:  Antioxid Redox Signal       Date:  2012-08-17       Impact factor: 8.401

Review 9.  Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis.

Authors:  Etty N Benveniste; Yudong Liu; Braden C McFarland; Hongwei Qin
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

10.  CD8 T cells regulate allergic contact dermatitis by modulating CCR2-dependent TNF/iNOS-expressing Ly6C+ CD11b+ monocytic cells.

Authors:  Shu Zhen Chong; Kar Wai Tan; Fiona H S Wong; Yen Leong Chua; Yafang Tang; Lai Guan Ng; Veronique Angeli; David M Kemeny
Journal:  J Invest Dermatol       Date:  2013-09-23       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.